Novel heterocyclic ring-fused oleanolic acid derivatives as osteoclast inhibitors for osteoporosis
作者:Jing Wu、Bei-Hua Bao、Qi Shen、Yu-Chao Zhang、Qing Jiang、Jian-Xin Li
DOI:10.1039/c5md00482a
日期:——
A series of novel oleanolic acid (OA) derivatives were synthesized via modifications of the A-ring and C28-amides of OA, and their anti-bone resorption activities were evaluated in vitro and in vivo.
Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages
作者:Tadashi Honda、BarbieAnn V. Rounds、Gordon W. Gribble、Nanjoo Suh、Yongping Wang、Michael B. Sporn
DOI:10.1016/s0960-894x(98)00479-x
日期:1998.10
New derivatives with electron-withdrawing substituents at the C-2 position of 3-oxoolean-1-en-28-oic acid were synthesized. Among them, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO) was 400 times more potent than previous compounds we have made as an inhibitor of production of nitric oxide induced by interferon-gamma in mouse macrophages (IC50, 0.4 nM). The potency of CDDO was similar to that of dexamethasone, although CDDO does not act through the glucocorticoid receptor. (C) 1998 Elsevier Science Ltd. All rights reserved.
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B
A series of maslinic acid derivatives have been synthesized by introducing various fused heterocyclic rings at C-2 and C-3 positions. Their inhibitory effects on PTP1B, TCPTP and related PTPs are evaluated. Most of the compounds exhibited a dramatic increase in inhibitory potency and selectivity, the two most potent PTP1B inhibitors 20 (IC50 = 0.61 mu M) and 29 (IC50 = 0.64 mu M) showed about 10-fold more potent than lead compound maslinic acid. More importantly, 29 possesses the best selectivity of 6.9-fold for PTP1B over TCPTP. (C) 2009 Elsevier Ltd. All rights reserved.
THERAPEUTIC COMPOUNDS AND METHODS OF USE
申请人:Gribble Gordon W.
公开号:US20130237721A1
公开(公告)日:2013-09-12
Compounds and methods useful for chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis.